Related Experiment Video
Updated: Jan 22, 2026

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
Published on: September 30, 2019
Protein Chemical Synthesis Combined with Mirror-Image Phage Display Yields d-Peptide EGF Ligands that Block the
Cristina Díaz-Perlas1, Monica Varese1, Salvador Guardiola1
1Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Baldiri Reixac 10, Barcelona, 08028, Spain.
Abstract:
The epidermal growth factor (EGF) pathway, being overactive in a number of cancers, is a good target for clinical therapy. Although several drugs targeting the EGF receptor (EGFR) are on the market, tumours acquire resistance very rapidly. As an alternative, small molecules and peptides targeting EGF have been developed, although with moderate success. Herein, we report the use of mirror-image phage display technology to discover protease-resistant peptides with the capacity to inhibit the EGF-EGFR interaction. After the chemical synthesis of the enantiomeric protein d-EGF, two phage-display peptide libraries were used to select binding sequences. The d versions of these peptides bound to natural EGF, as confirmed by surface acoustic waves (SAWs). High-field NMR spectroscopy showed that the best EGF binder, d-PI_4, interacts preferentially with an EGF region that partially overlaps with the receptor binding interface. Importantly, we also show that d-PI_4 efficiently disrupts the EGF-EGFR interaction. This methodology represents a straightforward approach to find new protease-resistant peptides with potential applications in cancer therapy.
Insights
Researchers developed protease-resistant peptides to inhibit cancer-driving epidermal growth factor (EGF) signaling. These novel d-peptides show potential for new cancer therapies by blocking EGF-EGFR interactions.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- The epidermal growth factor (EGF) pathway is frequently overactive in various cancers, making it a significant therapeutic target.
- Existing drugs targeting the EGF receptor (EGFR) often face rapid tumor resistance.
- Alternative strategies using small molecules and peptides targeting EGF have shown limited success.
Purpose of the Study:
- To discover protease-resistant peptides capable of inhibiting the EGF-EGFR interaction using mirror-image phage display technology.
- To develop novel therapeutic agents for cancer treatment by targeting the EGF pathway.
Main Methods:
- Chemical synthesis of the enantiomeric protein d-EGF.
- Selection of binding sequences using two phage-display peptide libraries against d-EGF.
- Confirmation of d-peptide binding to natural EGF using surface acoustic waves (SAWs).
- Structural analysis of EGF-peptide interactions using high-field NMR spectroscopy.
Main Results:
- Identified a potent EGF binder, d-PI_4, which interacts with a region overlapping the EGFR binding interface.
- Demonstrated that d-PI_4 effectively disrupts the EGF-EGFR interaction.
- Confirmed the protease-resistant nature of the discovered d-peptides.
Conclusions:
- Mirror-image phage display is an effective method for discovering protease-resistant peptides.
- The identified peptide d-PI_4 shows promise for inhibiting EGF-EGFR signaling.
- This approach offers a straightforward strategy for developing new peptide-based cancer therapeutics.
Related Concept Videos
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding and Linkage
Reaction Yield
Synthesis and Decomposition Reactions
Peptide Bonds
ATP Yield
The ETC is embedded in the inner mitochondrial membrane and is comprised of four main protein complexes and an ATP synthase. NADH and FADH2 pass electrons to these complexes, which pump protons into the intermembrane space. This distribution of...

